mhurhangee/patent-ind-claim-en huggingface dataset:
A device for transcatheter treatment for tricuspid regurgitation, the device comprising: a cerclage wire ; a coronary sinus tube adapted to be inserted into the coronary sinus; and a tricuspid valve tube adapted to traverse the tricuspid valve,wherein the coronary sinus tube and the tricuspid valve tube communicate with each other or are adjacent to each other within a range of predetermined length at an upper side and are separate from each other at a lower side, a blocking member for blocking a space generated by incomplete closing of the tricuspid valve is provided at the lower part of the tricuspid valve tube or between the coronary sinus tube and the tricuspid valve tube , characterized in that a stopper for preventing an end of the tricuspid valve tube from piercing into the interventricular septum is provided at the lower side of the tricuspid valve tube , a movable tube adapted for moving the stopper is inserted into the tricuspid valve tube , and the stopper is provided at a lower end of the movable tube for moving the stopper , and is adapted to be moved along the cerclage wire according to movement of the movable tube for moving the stopper . a cerclage wire ; a coronary sinus tube adapted to be inserted into the coronary sinus; and a tricuspid valve tube adapted to traverse the tricuspid valve,wherein the coronary sinus tube and the tricuspid valve tube communicate with each other or are adjacent to each other within a range of predetermined length at an upper side and are separate from each other at a lower side, a blocking member for blocking a space generated by incomplete closing of the tricuspid valve is provided at the lower part of the tricuspid valve tube or between the coronary sinus tube and the tricuspid valve tube , characterized in that a stopper for preventing an end of the tricuspid valve tube from piercing into the interventricular septum is provided at the lower side of the tricuspid valve tube , a movable tube adapted for moving the stopper is inserted into the tricuspid valve tube , and the stopper is provided at a lower end of the movable tube for moving the stopper , and is adapted to be moved along the cerclage wire according to movement of the movable tube for moving the stopper .
Placement device for an inflatable gastric balloon for the placement of the gastric balloon in a stomach, the gastric balloon having a deflated state and an inflated state, the placement device comprising: - an elastically deformable casing delimiting a cavity configured to receive the gastric balloon in the deflated state, the casing extending along a longitudinal axis (L) and comprising a lateral wall extending around the longitudinal axis (L) between a connection end and an insertion end , - a duct configured to be supplied with a fluid and to convey the fluid to inflate the gastric balloon , the duct being attached to the connection end of the casing , and comprising an end piece configured to removably attach the gastric balloon ; - the end piece having an inflation position in which said end piece extends into the cavity of the casing ; characterized in that the lateral wall of the casing has a lateral opening configured to allow the gastric balloon to exit the cavity , when said gastric balloon passes from the deflated state to the inflated state. - an elastically deformable casing delimiting a cavity configured to receive the gastric balloon in the deflated state, the casing extending along a longitudinal axis (L) and comprising a lateral wall extending around the longitudinal axis (L) between a connection end and an insertion end , - a duct configured to be supplied with a fluid and to convey the fluid to inflate the gastric balloon , the duct being attached to the connection end of the casing , and comprising an end piece configured to removably attach the gastric balloon ; - the end piece having an inflation position in which said end piece extends into the cavity of the casing ;
An all secondary bundle large scale field erected air cooled industrial steam condenser connected to an industrial steam producing facility, comprising: two bundles each comprising a plurality of finned flattened tubes fitted adjacent to one-another, each of said bundles oriented so that the longitudinal axis of said finned flattened tubes is positioned at an angle of 55°-65° from horizontal; a combined steam distribution-condensate collection manifold attached to a bottom of each of said bundles and running along a length of said bundles configured both to deliver steam to a bottom of said tubes and to collect condensate that forms in said tube from said steam as it cools; a non-condensable collection manifold attached to a top of each of said bundles and running along a length of said bundles parallel to said steam distribution manifold and configured to collect non-condensable gases from said steam, wherein the condenser comprises no primary condenser tubes two bundles each comprising a plurality of finned flattened tubes fitted adjacent to one-another, each of said bundles oriented so that the longitudinal axis of said finned flattened tubes is positioned at an angle of 55°-65° from horizontal; a combined steam distribution-condensate collection manifold attached to a bottom of each of said bundles and running along a length of said bundles configured both to deliver steam to a bottom of said tubes and to collect condensate that forms in said tube from said steam as it cools; a non-condensable collection manifold attached to a top of each of said bundles and running along a length of said bundles parallel to said steam distribution manifold and configured to collect non-condensable gases from said steam, wherein the condenser comprises no primary condenser tubes
An in vitro method for analyzing at least one blood parameter in a whole blood sample of a patient comprising: a) determining the in vivo hemolysis in a fresh whole blood sample of the patient by immediately performing the hemolysis determination after the blood sample has been obtained from the patient; b) determining the overall hemolysis and the at least one blood parameter in a whole blood sample of the patient; and characterized in that the method is further comprising c) calculating the in vitro hemolysis based on the overall hemolysis and the in vivo hemolysis. a) determining the in vivo hemolysis in a fresh whole blood sample of the patient by immediately performing the hemolysis determination after the blood sample has been obtained from the patient; b) determining the overall hemolysis and the at least one blood parameter in a whole blood sample of the patient; and characterized in that the method is further comprising c) calculating the in vitro hemolysis based on the overall hemolysis and the in vivo hemolysis.
A quay crane, comprising a double-trapezoid four-track girder , whereby upper-trolley running tracks (a16) on inner sides of the double-trapezoid four-track girder are configured for an upper trolley to travel on, a lower trolley is suspended upside down on lower-trolley running tracks (a8) on outer sides of the double-trapezoid four-track girder , and a container hoisted by the upper trolley via a hoist is able to pass through the lower trolley ; characterised in that the double-trapezoid four-track girder comprises original box beams (a4), plates-A (a5), plates-B (a6), and track bearing beams (a7); tops of the two original box beams (a4) are interconnected by a connecting frame (a11) of a quay crane, structures of the two original box beams (a4) are symmetrically disposed relative to the center of the connecting frame (a11), sections of bottom parts of the two original box beams (a4) are of right-angled trapezoids, each of the right-angled trapezoids comprises a right-angled side (a12), an oblique side (a13), an upper base (a14), and a lower base (a15), the oblique sides (a13) of the bottom parts of the two original box beams (a4) are both located on inner sides of the quay crane, the right-angled sides (a12) thereof are both located on outer sides of the quay crane, and the two oblique sides (a13) are provided with the upper-trolley running tracks (a16) which are symmetrically arranged; each of the plates-B (a6) is laid along the longitudinal direction of a corresponding original box beam (a4), each of the plates-B (a6) is located on an outer side of a corresponding lower base (a15), one side of each of the plates-B (a6) is connected with one side of the corresponding lower base (a15), and each of the plates-B (a6) is located on the same horizontal height as the corresponding lower base (a15); each of the plates-A (a5) is laid along the longitudinal direction of a corresponding original box beam (a4), one side of each of the plates-A (a5) is connected with the other side, away from a corresponding lower base (a15), of a corresponding plate-B (a6), and the other side of each of the plates-A (a5) is connected with an outer side of the corresponding original box beam (a4); and each of the track bearing beams (a7) is mounted on one end, away from a corresponding lower base (a15), of a corresponding plate-B (a6), and each of the lower-trolley running tracks (a8) is laid on a corresponding track bearing beam (a7).
A capacitive touch screen panel, comprising: an array comprising a plurality of first sensing electrodes interspersed with a plurality of second sensing electrodes located on a substrate ; a plurality of first connecting patterns , each first connecting pattern connecting a first sensing electrode of the plurality of first sensing electrodes to an adjacent first sensing electrode of the plurality of first sensing electrodes in a first direction; a plurality of second connecting patterns , each second connecting pattern connecting a second sensing electrode of the plurality of second sensing electrodes to an adjacent second sensing electrode of the plurality of second sensing electrodes in a second direction, wherein the first direction is different from the second direction; a first insulating layer at least between the first connecting patterns and the second connecting patterns ; dummy patterns situated in at least one of the first and second sensing electrodes , the dummy patterns being insulated from the first and second sensing electrodes ; wherein: the dummy patterns are adjacent to an intersection of the plurality of first sensing electrodes with the plurality of second sensing electrodes ; and the dummy patterns include second dummy patterns contacting a region between the first and second sensing electrodes . an array comprising a plurality of first sensing electrodes interspersed with a plurality of second sensing electrodes located on a substrate ; a plurality of first connecting patterns , each first connecting pattern connecting a first sensing electrode of the plurality of first sensing electrodes to an adjacent first sensing electrode of the plurality of first sensing electrodes in a first direction; a plurality of second connecting patterns , each second connecting pattern connecting a second sensing electrode of the plurality of second sensing electrodes to an adjacent second sensing electrode of the plurality of second sensing electrodes in a second direction, wherein the first direction is different from the second direction; a first insulating layer at least between the first connecting patterns and the second connecting patterns ; dummy patterns situated in at least one of the first and second sensing electrodes , the dummy patterns being insulated from the first and second sensing electrodes ; wherein: the dummy patterns are adjacent to an intersection of the plurality of first sensing electrodes with the plurality of second sensing electrodes ; and the dummy patterns include second dummy patterns contacting a region between the first and second sensing electrodes . the dummy patterns are adjacent to an intersection of the plurality of first sensing electrodes with the plurality of second sensing electrodes ; and the dummy patterns include second dummy patterns contacting a region between the first and second sensing electrodes .
A composition for use in a method for the treatment of pain in a mammal suffering from pain, wherein the method comprises topically administering the composition to said mammal, the composition comprising: (a) 2-30% by weight of a TRPV1 selective agonist, wherein the TRPV1 selective agonist is a capsaicinoid; and (b) 50-95% by weight of an analgesic agent capable of solubilising the capsaicinoid, wherein the analgesic agent comprises: i) a methyl salicylate and ii) a TRPM8 agonist or a TRPV3 agonist; wherein said composition has an amount of analgesic agent sufficient to eliminate or reduce the burning and/or stinging sensation or erythema created by the topical administration of the capsaicinoid. (a) 2-30% by weight of a TRPV1 selective agonist, wherein the TRPV1 selective agonist is a capsaicinoid; and (b) 50-95% by weight of an analgesic agent capable of solubilising the capsaicinoid, wherein the analgesic agent comprises: i) a methyl salicylate and ii) a TRPM8 agonist or a TRPV3 agonist; wherein said composition has an amount of analgesic agent sufficient to eliminate or reduce the burning and/or stinging sensation or erythema created by the topical administration of the capsaicinoid. i) a methyl salicylate and ii) a TRPM8 agonist or a TRPV3 agonist; wherein said composition has an amount of analgesic agent sufficient to eliminate or reduce the burning and/or stinging sensation or erythema created by the topical administration of the capsaicinoid.
A method of producing tea syrup, the method comprising: - contacting a plant material and/or plant extract comprising tea leaves and/or tea buds with water at a temperature of at least 60°C to produce a tea, wherein the concentration of the plant material and/or plant extract in the water is at least 50 grams per litre; - filtering the tea to produce a tea filtrate, wherein the tea is at a temperature of at least 50°C when it is filtered; - adding sugar to the tea filtrate at a concentration sufficient to cause the tea syrup to have a Brix value of at least 50°Bx; and - reducing the pH of either the tea or the tea filtrate to between 2.8 and 4.5, and thereby producing a tea syrup, wherein the tea syrup has a water activity of less than 0.90. - contacting a plant material and/or plant extract comprising tea leaves and/or tea buds with water at a temperature of at least 60°C to produce a tea, wherein the concentration of the plant material and/or plant extract in the water is at least 50 grams per litre; - filtering the tea to produce a tea filtrate, wherein the tea is at a temperature of at least 50°C when it is filtered; - adding sugar to the tea filtrate at a concentration sufficient to cause the tea syrup to have a Brix value of at least 50°Bx; and - reducing the pH of either the tea or the tea filtrate to between 2.8 and 4.5, and thereby producing a tea syrup, wherein the tea syrup has a water activity of less than 0.90.
A solar receiver comprising a metamaterials-enhanced sunlight-receiving structure consisting essentially of a high melting point base material having a first surface comprising a plurality of substantially cube-shaped microcavities surrounded by associated interlaced walls that are disposed a periodic array having a grating period in the range of 0.5 to 2 microns, characterised in that two or more of the interlaced walls have different thicknesses.
A test system for testing a device having a plurality of electrical contacts, the test system comprising: a device table operable to hold at least one device under test, the device table comprising two or more reference structures extending out of or into the device table , wherein at least two of the reference structures extend out of or into the device table by different distances; a probe comprising at least one probe end for contacting electrical contacts of a device under test; and a movement mechanism operable to move one or both of the device table and the probe so as to bring the at least one probe end into contact with at least one electrical contact of a device under test; wherein the two or more reference structures provide references at different distances to determine the position of electrical contacts of a device under test, relative to the reference structures . a device table operable to hold at least one device under test, the device table comprising two or more reference structures extending out of or into the device table , wherein at least two of the reference structures extend out of or into the device table by different distances; a probe comprising at least one probe end for contacting electrical contacts of a device under test; and a movement mechanism operable to move one or both of the device table and the probe so as to bring the at least one probe end into contact with at least one electrical contact of a device under test; wherein the two or more reference structures provide references at different distances to determine the position of electrical contacts of a device under test, relative to the reference structures .
A cell system , comprising: a laminated battery , a plurality of battery cells being laminated in the laminated battery; a first switch connected to a positive electrode of the laminated battery and configured to switch connection to the positive electrode to a shut-off state; a second switch connected to a negative electrode of the laminated battery and configured to switch connection to the negative electrode to a shut-off state; a circuit to be connected at least either between the positive electrode and the first switch or between the negative electrode and the second switch ; characterized in that the cell system further comprises: a controller configured to shift control timings of the first switch and the second switch from the shut-off state to a connected state according to an electrical capacitance generated between the positive electrode and the negative electrode so as to decrease a surge current flowing to the circuit from the electrical capacitance. a laminated battery , a plurality of battery cells being laminated in the laminated battery; a first switch connected to a positive electrode of the laminated battery and configured to switch connection to the positive electrode to a shut-off state; a second switch connected to a negative electrode of the laminated battery and configured to switch connection to the negative electrode to a shut-off state; a circuit to be connected at least either between the positive electrode and the first switch or between the negative electrode and the second switch ; characterized in that the cell system further comprises: a controller configured to shift control timings of the first switch and the second switch from the shut-off state to a connected state according to an electrical capacitance generated between the positive electrode and the negative electrode so as to decrease a surge current flowing to the circuit from the electrical capacitance.
A method for screening a compound useful for treating pain, inflammation, or pruritus, comprising the steps of: preparing a cell membrane containing GPR83; bringing a compound assumed to be an antagonist against the function of the hemokinin 1 (HK-1) receptor into contact with the cell membrane; confirming whether the compound binds to GPR83 and thus exhibits antagonist activity; and screening a compound useful for treating pain, inflammation, or pruritus, wherein GPR83 is: (i) a polypeptide consisting of the amino acid sequence represented by any one of SEQ ID NOS: 17 to 20; (ii) a polypeptide comprising the amino acid sequence represented by any one of SEQ ID NOS: 17 to 20, and having HK-1 receptor activity; (iii) a polypeptide consisting of an amino acid sequence that has a deletion, a substitution, and/or an addition of 1 to 10 amino acids with respect to the amino acid sequence of any one of the polypeptides (i) to (ii), and having HK-1 receptor activity; or (iv) a polypeptide comprising an amino acid sequence that has at least 90% sequence identity with the amino acid sequence of any one of the polypeptides (i) to (ii), and having HK-1 receptor activity. preparing a cell membrane containing GPR83; bringing a compound assumed to be an antagonist against the function of the hemokinin 1 (HK-1) receptor into contact with the cell membrane; confirming whether the compound binds to GPR83 and thus exhibits antagonist activity; and screening a compound useful for treating pain, inflammation, or pruritus, wherein GPR83 is: (i) a polypeptide consisting of the amino acid sequence represented by any one of SEQ ID NOS: 17 to 20; (ii) a polypeptide comprising the amino acid sequence represented by any one of SEQ ID NOS: 17 to 20, and having HK-1 receptor activity; (iii) a polypeptide consisting of an amino acid sequence that has a deletion, a substitution, and/or an addition of 1 to 10 amino acids with respect to the amino acid sequence of any one of the polypeptides (i) to (ii), and having HK-1 receptor activity; or (iv) a polypeptide comprising an amino acid sequence that has at least 90% sequence identity with the amino acid sequence of any one of the polypeptides (i) to (ii), and having HK-1 receptor activity. (i) a polypeptide consisting of the amino acid sequence represented by any one of SEQ ID NOS: 17 to 20; (ii) a polypeptide comprising the amino acid sequence represented by any one of SEQ ID NOS: 17 to 20, and having HK-1 receptor activity; (iii) a polypeptide consisting of an amino acid sequence that has a deletion, a substitution, and/or an addition of 1 to 10 amino acids with respect to the amino acid sequence of any one of the polypeptides (i) to (ii), and having HK-1 receptor activity; or (iv) a polypeptide comprising an amino acid sequence that has at least 90% sequence identity with the amino acid sequence of any one of the polypeptides (i) to (ii), and having HK-1 receptor activity.
A method for removing red blood cells from a suspension comprising red blood cells, white blood cells, platelets and plasma using a spinning membrane separator, the spinning membrane separator comprising a housing, a rotor rotatably supported within the housing, a membrane affixed to the rotor having a porous surface that permits plasma and platelets to pass therethrough but not red blood cells and white blood cells, with a gap being defined between the housing and the membrane, the method comprising: a) flowing whole blood into the gap; b) collecting red blood cells and white blood cells in the gap and passing plasma and platelets through the membrane; c) introducing a first quantity of lysing buffer into the gap; d) incubating the red blood cells, white blood cells and lysing buffer in the gap for a period of time to cause a lysis reaction with the red blood cells; e) introducing a second quantity of lysing buffer into the gap to displace the first quantity of lysing buffer and a first quantity of red blood cell debris out of the gap and through the membrane; f) introducing a first quantity of wash buffer into the gap to quench the lysis reaction and displace the second quantity of lysing buffer and a second quantity of red blood cell debris out of the gap and through the membrane; and g) introducing a second quantity of wash buffer into the gap to flow washed white blood cells out of the housing. a) flowing whole blood into the gap; b) collecting red blood cells and white blood cells in the gap and passing plasma and platelets through the membrane; c) introducing a first quantity of lysing buffer into the gap; d) incubating the red blood cells, white blood cells and lysing buffer in the gap for a period of time to cause a lysis reaction with the red blood cells; e) introducing a second quantity of lysing buffer into the gap to displace the first quantity of lysing buffer and a first quantity of red blood cell debris out of the gap and through the membrane; f) introducing a first quantity of wash buffer into the gap to quench the lysis reaction and displace the second quantity of lysing buffer and a second quantity of red blood cell debris out of the gap and through the membrane; and g) introducing a second quantity of wash buffer into the gap to flow washed white blood cells out of the housing.